Prostate Cancer
Biopsy and Erectile Functional Outcomes of Partial Prostate Ablation: A Systematic Review and Meta-Analysis of Prospective Studies.
October 3, 2023
Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer.
October 3, 2023
The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.
October 3, 2023
Comparative analysis of robot-assisted simple prostatectomy: the HUGO™ RAS system versus the DaVinci® Xi system.
October 2, 2023
Oncological and functional results of focal treatment of localized prostate cancer with HIFU.
October 2, 2023
High dose rate brachytherapy for prostate cancer: A prospective toxicity evaluation of a one day schedule including two 13.5 Gy fractions.
October 1, 2023
Direct Patlak Reconstruction of [68Ga]Ga-PSMA PET for the Evaluation of Primary Prostate Cancer Prior Total Prostatectomy: Results of a Pilot Study.
September 29, 2023
T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence.
September 29, 2023
Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer.
September 29, 2023
MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation.
September 29, 2023
Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer.
September 29, 2023
The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer.
September 28, 2023